A study led by Harvard Medical School researchers shed new light on how even a single defective copy of the tumor-suppressor BRCA1 gene can increase patients’ risk of developing breast cancer.

BRCA1 is a tumor suppressor gene that is mutated in a high percentage of hereditary breast and ovarian cancers (Futreal et al., 1994). BRCA1 has also been implicated in some cases of sporadic breast ...

A new study has revealed a ‘morning after pill’ drug already approved for use in the NHS could be repurposed to prevent ...

Dr. Katz's research shows how important it is for all breast cancer survivors to have access to genetic testing services, ...

Learn about breast cancer and genetic testing including risks, benefits, privacy concerns and how testing helps guide prevention and personalised care decisions ...

Hope is on the horizon for patients with aggressive, inherited breast cancers. A recent clinical trial, led by researchers at Cambridge University, explored the effects of combining chemotherapy with ...

JOHNSTOWN, Pa. – With September’s Ovarian Cancer Awareness Month campaign wrapping up, health care providers are shifting their focus to October’s Breast Cancer Awareness Month events. They are ...

Angelina Jolie has opened up about undergoing a double mastectomy and having her ovaries removed after discovering she carried the BRCA1 gene mutation. This gene puts her at an 87% lifetime risk of ...

Prostate cancer guidelines should change so that all men from the age of 40 with mutations in either the BRCA1 or BRCA2 gene are offered regular PSA testing to detect early signs of the disease, ...